Amaryl Generics Hit The Market, Led By Prasco's "Authorized" Product
This article was originally published in The Pink Sheet Daily
Executive Summary
Corepharma, Dr. Reddy's, Invagen, Ranbaxy and Teva receive final approval for generics of Sanofi-Aventis' Amaryl.
You may also be interested in...
Takeda’s Combo Duetact Will Launch Later This Year For Type 2 Diabetes
Takeda's existing Actos sales force will detail the pioglitazone and glimepiride combination therapy to primary care physicians.
Takeda’s Combo Duetact Will Launch Later This Year For Type 2 Diabetes
Takeda's existing Actos sales force will detail the pioglitazone and glimepiride combination therapy to primary care physicians.
Prasco To Launch Allegra “Authorized” Generic
Licensed version of Sanofi-Aventis’ antihistamine will begin shipping more than two weeks after Teva’s fexofenadine generic launched “at risk.”